Vesicular stomatitis Indiana virus
-
Subject Areas on Research
- A comparison of the extents of methylation of vesicular stomatitis virus messenger RNA.
- A host protein (La) binds to a unique species of minus-sense leader RNA during replication of vesicular stomatitis virus.
- A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles.
- An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.
- Base mutations in the terminal noncoding regions of the genome of vesicular stomatitis virus isolated from persistent infections of L cells.
- Characterization of the 3' terminus of RNA isolated from vesicular stomatitis virus and from its defective interfering particles.
- Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.
- DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.
- Efficient cross-priming of antiviral CD8+ T cells by antigen donor cells is GRP94 independent.
- HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells.
- Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol.
- In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus.
- Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector.
- Inhibitory effects of vesicular stomatitis virus on cellular and influenza viral RNA metabolism and protein synthesis.
- Interactions between small viral RNAs of vesicular stomatitis virus and components of cellular gene expression.
- Interactions of plus and minus strand leader RNAs of the New Jersey serotype of vesicular stomatitis virus with the cellular La protein.
- Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA.
- MOV10 Provides Antiviral Activity against RNA Viruses by Enhancing RIG-I-MAVS-Independent IFN Induction.
- Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.
- Nucleotide sequence and host La protein interactions of rabies virus leader RNA.
- Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles.
- Polycistronic vesicular stomatitis virus RNA transcripts.
- Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.
- Protein synthesis-dependent potentiation by thyroxine of antiviral activity of interferon-gamma.
- Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
- RNA polymerase-associated interactions near template promoter sequences of defective interfering particles of vesicular stomatitis virus.
- Rapid and transient localization of the leader RNA of vesicular stomatitis virus in the nuclei of infected cells.
- Rapid inhibition of processing and assembly of small nuclear ribonucleoproteins after infection with vesicular stomatitis virus.
- Reduced thymic maturation but normal effector function of CD8+ T cells in CD8 beta gene-targeted mice.
- Replication of the vesicular stomatitis virus genome in permissive and nonpermissive host cells.
- Sequence-specific contacts between the RNA polymerase of vesicular stomatitis virus and the leader RNA gene.
- Sequential synthesis of small capped RNA transcripts in vitro by vesicular stomatitis virus.
- Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.
- Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA.
- Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs.
- Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus.
- Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved.
- The Mitochondrial Phosphatase PGAM5 Is Dispensable for Necroptosis but Promotes Inflammasome Activation in Macrophages.
- The complete sequence of a unique RNA species synthesized by a DI particle of VSV.
- The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies.
- The metabolic fate of independently initiated VSV mRNA transcripts.
- Transfer RNAs associated with vesicular stomatitis virus.
- VSV transmembrane domain (TMD) peptide promotes PEG-mediated fusion of liposomes in a conformationally sensitive fashion.
- Vesicular stomatitis virus defective interfering particle containing a muted internal leader RNA gene.
- Viral transcription is necessary and sufficient for vesicular stomatitis virus to inhibit maturation of small nuclear ribonucleoproteins.
- Viruses as therapeutic agents against malignant disease of the central nervous system.